Rift Valley fever virus, SPU276/10


EVAg

Originator
:
www.nicd.ac.za
Produced by
:
Shipping From
: -

Product Description

Ref-SKU:
018V-01784
Infectious cell culture supernatant, partial sequencing, mycoplasma tested, infectivity tested and quantified (TCID50/ml)
Product Risk Group: 
Genotype: 

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Partial sequence
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
0.5 ml/vial

550,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Biosafety restrictions: 
Risk group allocations may vary on country level, typically considered RG3
Infectivity Test: 
End point titration with calculation of tissue culture infectious dose 50 in Vero cell culture
Viral titer: 
10(4) TCID50/ml (minimum supplied)
Production cell line: 
Genbank reference: 
Passage: 
2
Identification technique: 
Verified by RT-PCR and sequencing
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Collection date: 
Friday, 1 January, 2010
Suspected epidemiological origin : 
Isolation host: 
Isolation technique: 
Cell culture inoculation (Vero cell culture)